Apogee Therapeutics, Inc.

Biotechnology company · San Francisco, California, United States · Nasdaq: APGE

Apogee Therapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its shares trade on Nasdaq under the ticker APGE.

Profile compiled from public records. Is this your company? Request a correction or update

Apogee Therapeutics at a glance

Typebiotechnology company

HeadquartersSan Francisco, California, United States

Stock listingNasdaq: APGE

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1974640

Frequently asked questions about Apogee Therapeutics

Where is Apogee Therapeutics headquartered?

Apogee Therapeutics, Inc. is headquartered in San Francisco, California, United States.

What does Apogee Therapeutics do?

Apogee Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Apogee Therapeutics a public company?

Yes. Apogee Therapeutics, Inc. trades on Nasdaq under the ticker APGE.

Similar companies

Ossium Health, Inc.San Francisco, California, United States
Vir Biotechnology, Inc.San Francisco, California, United States
Titan Pharmaceuticals IncSan Francisco, California, United States
Senti Biosciences, Inc.San Francisco, California, United States
Amygdala Neurosciences IncSan Francisco, California, United States
Excision BioTherapeutics IncSan Francisco, California, United States
ProLynx, Inc.San Francisco, California, United States
Second Genome, Inc.San Francisco, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences